Featured Research

from universities, journals, and other organizations

Researchers Identify Eye Disorder Gene

Date:
April 4, 2005
Source:
Vanderbilt University Medical Center
Summary:
Investigators at Vanderbilt University Medical Center and Duke University Medical Center have identified the first major gene that increases a person's risk of developing age-related macular degeneration (AMD).

Investigators at Vanderbilt University Medical Center and Duke University Medical Center have identified the first major gene that increases a person's risk of developing age-related macular degeneration (AMD).

AMD is a progressive eye condition that affects as many as 15 million people in the United States and is the leading cause of vision loss and legal blindness in people over age 60.

The researchers report this week in Science Express, the online version of the journal Science, that a common variant of the gene for Complement Factor H accounts for up to 43 percent of age-related macular degeneration.

The finding “opens the door toward the possibility of pre-symptomatic testing and potentially even pre-symptomatic treatment,” said first author Jonathan L. Haines, Ph.D., director of the Vanderbilt Center for Human Genetics Research. It also sheds light on the biological mechanisms underlying the disease and offers real hope for drug development, he said.

“Knowing this gene now narrows us from millions of potential targets for drug treatment and drug development to one. That's not bad,” Haines said.

Vision loss often occurs late in the progression of AMD, and current treatments help stabilize the disease but do not reverse its course, said Anita Agarwal, M.D., assistant professor at the Vanderbilt Eye Institute and study co-author. “Less than 2 percent of patients show improvement in vision with treatment when the center of the macula is involved by abnormal blood vessels,” she said.

“No one knows if available treatments — sometimes as simple as dietary changes — might prevent vision loss if they were given ten years earlier,” Haines said. “Now we potentially have a way of screening for patients at high risk and doing early intervention trials.”

The toll of AMD is expected to mount as the U.S. population ages, Agarwal said. The disease affects nearly 30 percent of people over age 75, she said. Severe AMD robs affected individuals of the sharp central vision necessary for everyday activities like reading, driving, watching television, safely navigating stairs, and identifying faces.

Although the underlying causes of AMD are unknown, risk factors include age, smoking, high blood pressure, exposure to harmful sunlight, obesity and diet. Genetics was also a known risk factor, although it was expected to be less important than the environmental factors, Haines said.

“No one expected the genetics to work out this way — that a single gene variant would potentially explain as much as 40 percent of a disease that affects millions of people,” Haines said.

Haines participated in an earlier multi-center effort that linked a DNA region on chromosome 1 to increased risk for AMD.

To find the gene, he and longtime collaborator Margaret Pericak-Vance, Ph.D., director of the Duke Center for Human Genetics, and their teams examined DNA samples from two independent data sets.

One data set contained 182 families including members with and without AMD; the other set contained 495 patients with AMD and 185 individuals without the disease.

The investigators used modern genomic technologies and data from the Human Genome Project to zero in on the Complement Factor H (CFH) gene. A single variation in the CFH gene was strongly associated with AMD.

CFH participates in regulating inflammation; it puts the “brakes” on to protect cells from overactive inflammatory processes.

Chronic inflammation has been implicated in AMD, Haines said, but it is not known whether inflammation is a primary cause of the disease or a secondary mechanism.

The finding that a CFH variant accounts for such a large percentage of AMD “suggests that inflammation may be a more important aspect of the disease than had previously been appreciated,” he said. The researchers hypothesize that the CFH variant does not function appropriately to keep inflammation in check, leading ultimately to vascular damage and the abnormal growth of blood vessels characteristic of severe AMD.

Vanderbilt co-authors include Lana Olson, Kylee Spencer and Nathalie Schnetz-Boutaud.

The research was supported by the National Eye Institute, the National Institute on Aging and the National Center for Research Resources.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Researchers Identify Eye Disorder Gene." ScienceDaily. ScienceDaily, 4 April 2005. <www.sciencedaily.com/releases/2005/03/050325233506.htm>.
Vanderbilt University Medical Center. (2005, April 4). Researchers Identify Eye Disorder Gene. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2005/03/050325233506.htm
Vanderbilt University Medical Center. "Researchers Identify Eye Disorder Gene." ScienceDaily. www.sciencedaily.com/releases/2005/03/050325233506.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins